Cargando…
T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19
BACKGROUND: T‐cell lymphopenia and functional impairment is a hallmark of severe acute coronavirus disease 2019 (COVID‐19). How T‐cell numbers and function evolve at later timepoints after clinical recovery remains poorly investigated. METHODS: We prospectively enrolled and longitudinally sampled 17...
Autores principales: | Taeschler, Patrick, Adamo, Sarah, Deng, Yun, Cervia, Carlo, Zurbuchen, Yves, Chevrier, Stéphane, Raeber, Miro E., Hasler, Sara, Bächli, Esther, Rudiger, Alain, Stüssi‐Helbling, Melina, Huber, Lars C., Bodenmiller, Bernd, Boyman, Onur, Nilsson, Jakob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347640/ https://www.ncbi.nlm.nih.gov/pubmed/35567391 http://dx.doi.org/10.1111/all.15372 |
Ejemplares similares
-
A distinct innate immune signature marks progression from mild to severe COVID-19
por: Chevrier, Stéphane, et al.
Publicado: (2020) -
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
por: Cervia, Carlo, et al.
Publicado: (2022) -
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures
por: Taeschler, Patrick, et al.
Publicado: (2022) -
Profound dysregulation of T cell homeostasis and function in patients with severe COVID‐19
por: Adamo, Sarah, et al.
Publicado: (2021) -
Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection
por: Adamo, Sarah, et al.
Publicado: (2021)